Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 63

Results For "NDA"

5510 News Found

Enveric reports key safety milestone for EB-003 reinforcing clinical development path
Biotech | May 25, 2026

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors


Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Clinical Trials | May 23, 2026

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
People | May 23, 2026

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.


Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
Clinical Trials | May 23, 2026

Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial

Clears major obesity endpoints at 80 weeks


WACKER launches contract research services to accelerate next-gen RNA & DNA therapies
R&D | May 23, 2026

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich


Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
People | May 22, 2026

Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business

Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.


Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations
People | May 22, 2026

Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations

Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing


Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
News | May 22, 2026

Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore

Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore


Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond